Suppr超能文献

术前右心室对血流动力学优化的反应对左心室辅助装置患者预后的影响

Impact of Pre-Operative Right Ventricular Response to Hemodynamic Optimization on Outcomes in Patients with LVADs.

作者信息

Duque Ernesto Ruiz, Alvarez Paulino, Yang Yingchi, Khalid Muhammad, Kshetri Rupesh, Doulamis Ilias P, Panos Anthony, Briasoulis Alexandros

机构信息

Division of Cardiovascular Diseases, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA.

Department of Surgery, The Johns Hopkins Hospital, Baltimore, MD 21287, USA.

出版信息

J Clin Med. 2022 Oct 17;11(20):6111. doi: 10.3390/jcm11206111.

Abstract

Background: Right ventricular failure (RVF) continues to affect patients supported with durable left ventricular assist devices (LVAD) and results in increased morbidity and mortality. Information regarding the impact of right ventricular response to pre-operative optimization on outcomes is scarce. Methods: Single-center retrospective analysis of consecutive patients who underwent first continuous flow LVAD implantation between 2006 and 2020. Patients with bi-ventricular support before LVAD or without hemodynamic data were excluded. Invasive hemodynamics at baseline and after pre-operative medical and/or temporary circulatory support were recorded. Patients were grouped in the following categories: A: No Hemodynamic RV dysfunction (RVD) at baseline; B: RVD with achievement of RV hemodynamic optimization goals; C: RVD without achievement of RV optimization goals. The main outcomes were right ventricular failure defined as inotropes >14 days after implantation, or postoperative right ventricular mechanical support, and all-cause mortality. Results: Overall, 128 patients were included in the study. The mean age was 58 ±12.5 years, 74.2% were males and, 68.7% had non-ischemic cardiomyopathy. Hemodynamic RVD was present in 70 (54.7%) of the patients at baseline. RV hemodynamic goals were achieved in 46 (79.31%) patients with RVD and in all the patients without RVD at baseline. Failure to achieve hemodynamic optimization goals was associated with a significantly higher risk of RVF after LVAD implantation (adjusted OR 4.37, 95% CI 1.14−16.76, p = 0.031) compared with no RVD at baseline and increased 1-year mortality compared with no RVD (adjusted HR 4.1, 95% CI 1.24−13.2, p = 0.02) and optimized RVD (adjusted HR 6.4, 95% CI 1.6−25.2, p = 0.008).Conclusion: Among patients with RVD, the inability to achieve hemodynamic optimization goals was associated with higher rates of RV failure and increased 1-year all-cause mortality post LVAD implantation.

摘要

背景

右心室衰竭(RVF)持续影响接受耐用左心室辅助装置(LVAD)支持的患者,并导致发病率和死亡率增加。关于术前优化治疗时右心室反应对预后影响的信息很少。方法:对2006年至2020年间首次接受连续血流LVAD植入的连续患者进行单中心回顾性分析。排除在LVAD植入前接受双心室支持或无血流动力学数据的患者。记录基线时以及术前药物和/或临时循环支持后的有创血流动力学数据。患者分为以下几类:A:基线时无血流动力学右心室功能障碍(RVD);B:RVD且达到右心室血流动力学优化目标;C:RVD但未达到右心室优化目标。主要结局为植入后使用血管活性药物超过14天定义的右心室衰竭、术后右心室机械支持以及全因死亡率。结果:总体而言,128例患者纳入研究。平均年龄为58±12.5岁,74.2%为男性,68.7%患有非缺血性心肌病。70例(54.7%)患者基线时存在血流动力学RVD。46例(79.31%)RVD患者以及所有基线时无RVD的患者达到了右心室血流动力学目标。与基线时无RVD相比,未达到血流动力学优化目标与LVAD植入后发生RVF的风险显著更高相关(校正OR 4.37,95%CI 1.14−16.76,p = 0.031),与无RVD相比1年死亡率增加(校正HR 4.1,95%CI 1.24−13.2,p = 0.02),与优化的RVD相比也增加(校正HR 6.4,95%CI 1.6−25.2,p = 0.008)。结论:在RVD患者中,无法达到血流动力学优化目标与更高的RV衰竭发生率以及LVAD植入后1年全因死亡率增加相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d433/9605231/b47b729886c0/jcm-11-06111-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验